Yong J. Choi
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer.
Journal: Cell communication and signaling : CCS
Published: November 12, 2025
High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader.
Journal: Experimental hematology & oncology
Published: January 23, 2025
Dickkopf-1 promotes tumor progression of gefitinib- resistant non-small cell lung cancer through cancer cell-fibroblast interactions.
Journal: Experimental hematology & oncology
Published: October 10, 2024
Prevention of radiotherapy-induced pro-tumorigenic microenvironment by SFK inhibitors.
Journal: Theranostics
Published: July 15, 2024
Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 04, 2023
Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells.
Journal: Archives of pharmacal research
Published: May 30, 2023
PLM-101 is a novel and potent FLT3/RET inhibitor with less adverse effects in the treatment of acute myeloid leukemia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 24, 2023
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment.
Journal: Journal for immunotherapy of cancer
Published: December 30, 2022
CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy.
Journal: Biomolecules & therapeutics
Published: February 11, 2022
Heterogeneity of glutamine metabolism in acquired-EGFR-TKI-resistant lung cancer.
Journal: Life sciences
Published: October 21, 2021
Last Updated: 09/26/2026